Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Study: Aspirin anti-cancer
A study conducted by the US National Institutes of Health showed that small doses of aspirin may increase the chances of overcoming cancer.
Bristol-Myers Squibb gets FDA breakthrough therapy status for Orencia to prevent GvHD
Bristol-Myers Squibb (BMS) has secured breakthrough therapy status from the US Food and Drug Administration (FDA) for its Orencia (abatacept) to prevent moderate to severe acut...
Diabetes drug has unexpected, broad implications for healthy aging
Metformin is the most commonly prescribed type 2 diabetes drug, yet scientists still do not fully know how it works to control blood sugar levels.
Acadia's Nuplazid could hit blockbuster heights after strong psychosis data: analyst
When Acadia trumpeted news that it would end a late-stage trial for its Nuplazid in dementia-related psychosis (DRP) early, it represented a big win for a drugmaker still stinging from a major...
Astellas inks $3B Audentes buyout to expand in gene therapy
Astellas Pharma is set to buy Audentes Therapeutics for $3 billion.
Ardelyx drug reduces elevated phosphate levels, late-stage study shows
(Reuters) - Ardelyx Inc’s experimental drug has shown promise in a late-stage study as a standalone therapy to reduce elevated blood phosphate levels in patients with chronic kidney disease ...
World first as artificial neurons developed to cure chronic diseases
Artificial neurons on silicon chips that behave just like the real thing have been invented by scientists – a first-of-its-kind achievement with enormous scope for medical devices to cure chronic di...
NICE approves breast cancer treatment through Cancer Drugs Fund
NICE has approved palbociclib through the Cancer Drugs Fund, meaning that women with advanced breast cancer who have already received hormone therapy will now be eligible for palbociclib on the NHS.
Sanofi agrees to sell Seprafilm to Baxter for $350 million
PARIS (Reuters) - Medical supply company Baxter International Inc (BAX.
Senate committee advances Hahn for FDA commissioner
The Senate health committee on Tuesday voted to advance President Donald Trump's pick to run the Food and Drug Administration.
Lynparza shows benefits in prostate cancer
Lynparza (olaparib) continues to go from strength to strength, as the MSD and AstraZeneca PARP inhibitor has now been shown to slow or stop tumour growth in some men with advanced prostate can...
Verrica Pharmaceuticals Announces FDA Filing Acceptance of New Drug Application for VP-102 for the Treatment of Molluscum Contagiosum
WEST CHESTER, Pa.
362
363
364
365
366
367
368
369
370
